Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Effects of Statins on Renin–Angiotensin System Publisher



Kiaie N1 ; Gorabi AM1 ; Reiner Z2 ; Jamialahmadi T3, 4 ; Ruscica M5 ; Sahebkar A6, 7, 8, 9
Authors

Source: Journal of Cardiovascular Development and Disease Published:2021


Abstract

Statins, a class of drugs for lowering serum LDL-cholesterol, have attracted attention because of their wide range of pleiotropic effects. An important but often neglected effect of statins is their role in the renin–angiotensin system (RAS) pathway. This pathway plays an integral role in the progression of several diseases including hypertension, heart failure, and renal disease. In this paper, the role of statins in the blockade of different components of this pathway and the underlying mechanisms are reviewed and new therapeutic possibilities of statins are suggested. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Related Docs
View other Related Docs
1. A Comprehensive Review on the Lipid and Pleiotropic Effects of Pitavastatin, Progress in Lipid Research (2021)
2. Implications on the Therapeutic Potential of Statins Via Modulation of Autophagy, Oxidative Medicine and Cellular Longevity (2021)
3. Effect of Statins on Serum Level of Hs-Crp and Crp in Patients With Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Mediators of Inflammation (2022)
Experts (# of related papers)
View all Related Experts
Keyhan Mohammadi (3)
Farshad Sharifi (1)
Other Related Docs
4. Regulatory Effects of Statins on Sirt1 and Other Sirtuins in Cardiovascular Diseases, Life (2022)
5. Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage, Current Molecular Pharmacology (2021)
6. Effects of Statins on the Biological Features of Mesenchymal Stem Cells and Therapeutic Implications, Heart Failure Reviews (2021)
7. Effect of Statins on the Plasma/Serum Levels of Inflammatory Markers in Patients With Cardiovascular Disease; a Systematic Review and Meta-Analysis of Randomized Clinical Trials, Inflammopharmacology (2022)
8. Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials, Current Pharmaceutical Design (2024)
9. Effect of Statins on the Blood Lipid Profile in Patients With Different Cardiovascular Diseases: A Systematic Review With Meta-Analysis of Randomized Clinical Trials, Current Medicinal Chemistry (2023)
10. Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications, Journal of Clinical Medicine (2019)
11. Statins Block Mammalian Target of Rapamycin Pathway: A Possible Novel Therapeutic Strategy for Inflammatory, Malignant and Neurodegenerative Diseases, Inflammopharmacology (2023)
12. Antiviral Effects of Statins, Progress in Lipid Research (2020)
13. Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review, Journal of Diabetes and Metabolic Disorders (2021)
14. Application of Nanotechnology to Improve the Therapeutic Benefits of Statins, Drug Discovery Today (2019)
15. A Historical Cohort Study to Investigation of Statins Safety in Covid-19 Hospitalized Patients, Therapies (2022)
16. Parenteral Systems for Statin Delivery: A Review, Lipids in Health and Disease (2019)
17. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
18. The Beneficial Effects of Hmg-Coa Reductase Inhibitors in the Processes of Neurodegeneration, Metabolic Brain Disease (2017)
19. Statins: Complex Outcomes But Increasingly Helpful Treatment Options for Patients, European Journal of Pharmacology (2019)
20. Investigating Lipid-Modulating Agents for Prevention or Treatment of Covid-19: Jacc State-Of-The-Art Review, Journal of the American College of Cardiology (2021)